Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-01-07

Clinical Trial Update: Ivermectin Treatment in Patients With Onchocerciasis-associated Epilepsy [Phase 4]

View source ↗

Summary

Phase 4 trial update on ivermectin treatment in patients with onchocerciasis-associated epilepsy has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IVERMECTIN (Ivermectin)

Snippet

Sponsor: Robert Colebunders | Conditions: Ivermectin, Onchocerciasis | Phase 4 | Status: COMPLETED